The US Food and Drug Administration (FDA) has broadened the approval to W. L. Gore & Associates for its GORE VIABAHN Endoprosthesis. The company can now market its product for use in patients with symptomatic peripheral arterial disease in iliac artery lesions with reference vessel diameters ranging from 4.0 - 12.0 mm. Till now, this range had been limited to 4.0 - 7.5 mm. Gore is, now,  the only company with a stent-graft approved for both the SFA and iliac arteries.